Recursion Pharmaceuticals, Inc. (RXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Group 1 - Recursion is experiencing significant momentum and is focused on translating insights into meaningful proof points, highlighted by their first platform-enabled clinical proof of concept [2][3] - The company is concentrating on specific areas within its platform that address bottlenecks in research and development, aiming for impactful outcomes [3] - Recursion emphasizes discipline in execution, financial stewardship, and operational practices to support its ambitious goals [3] Group 2 - The mission of Recursion is to decode biology to radically improve lives, maintaining a patient-centric approach [4]